President & Chief Executive Officer, Board Member

Chief Financial Officer

Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP

Dianthus enters exclusive license agreement with Leads Biolabs for DNTH212

The biggest biotech funding rounds in September 2025

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2025 AANEM Annual Meeting

Executive Director, CMC Quality Assurance

Dianthus Therapeutics is developing potentially best in class therapies for patients living with severe autoimmune diseases. The Executive Director, CMC Quality Assurance will lead and build a comprehensive QA team to ensure compliance with global GMP and GLP regulations, supporting the development and regulatory approval of all Dianthus products.

Manager, Human Resource Business Partner

Associate Director, Biologics CMC Analytical Development 

Senior Director of Quality Control and Analytical Development 

Director, Quality Systems and Compliance

Sign up with Google

Sign in with Google